135601-81-9 (（16R）-20-去甲基-25-甲基-16-羟基巴松,(16R)-20-Demethyl-25-methyl-16-hydroxyparsonsine)

7H-[1,5,10]Trioxacyclotetradecino[7,8,9-gh]pyrrolizine-2,5,9(8H)-trione,8-ethyl-3,4,11,13,15,16,16a,16b-octahydro-3,4,8-trihydroxy-7-methyl-3-(1-methylpropyl)-,(3R,4S,7R,8S,16aR,16bR)-;7H-[1,5,10]Trioxacyclotetradecino[7,8,9-gh]pyrrolizine-2,5,9(8H)-trione,8-ethyl-3,4,11,13,15,16,16a,16b-octahydro-3,4,8-trihy;Parsonsianidine;(+)-Parsonsianidine;22,26-Dinorparsonsine,24-ethyl-16-hydroxy-, (16S)-;CID 134714989;(16R)-20-Demethyl-25-methyl-16-hydroxyparsonsine;7H-[1,5,10]Trioxacyclotetradecino[7,8,9-gh]pyrrolizine-2,5,9(8H)-trione, 8-ethyl-3,4,11,13,15,16,16a,16b-octahydro-3,4,8-trihydroxy-7-methyl-3-(1-methylpropyl)-, (3R,4S,7R,8S,16aR,16bR)-;4-Butan-2-yl-9-ethyl-4,5,9-trihydroxy-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.016,19]nonadec-13-ene-3,6,10-trione;135601-81-9;

QFQNRSCMBIGVFI-VNEORSPPSA-N

1S/C22H33NO9/c1-5-12(3)22(29)17(24)18(25)31-13(4)21(28,6-2)19(26)30-11-14-7-9-23-10-8-15(16(14)23)32-20(22)27/h7,12-13,15-17,24,28-29H,5-6,8-11H2,1-4H3/t12?,13-,15-,16-,17-,21+,22-/m1/s1

O1C([C@]([C@@H](C(=O)O[C@H](C)[C@@](CC)(C(=O)OCC2=CCN3CC[C@@H]1[C@H]32)O)O)(C(C)CC)O)=O